Said researchers at the University of Alabama at Birmingham Comprehensive Cancer Middle.

A need for better ovarian malignancy screening tools The only available screening tests for ovarian cancer fail to catch early signs of the condition and often result in unnecessary surgical procedure, said researchers at the University of Alabama at Birmingham Comprehensive Cancer Middle Prednisolone online . The new study looked at a screening routine that combines ultrasound and a blood test for CA-125, a marker for women’s cancer. Results demonstrated the combo screening captured 70 % of the ovarian cancers within their late levels, when effective treatment options are limited. Understanding the search is intended by this screening limitation has intensified for a better way to detect ovarian cancers, often called the silent killer, stated Edward Partridge, M.D., director of the UAB Comprehensive Cancer Middle and the lead research author.